151 related articles for article (PubMed ID: 38074210)
1. Pregnancy in women with cystic fibrosis and diabetes: An audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era.
Davidson SJ; France M; Callaway LK; Lust K; Chambers D; Hopkins P; Bell SC; Burr L; Keating R; Barrett HL
Obstet Med; 2023 Dec; 16(4):217-221. PubMed ID: 38074210
[TBL] [Abstract][Full Text] [Related]
2. Gestational and pregestational diabetes in pregnant women with cystic fibrosis.
Oxman R; Roe AH; Ullal J; Putman MS
J Clin Transl Endocrinol; 2022 Mar; 27():100289. PubMed ID: 34984172
[TBL] [Abstract][Full Text] [Related]
3. Cystic Fibrosis-Related Diabetes Mellitus and Pregnancy: A Retrospective Study.
Davern R; Balan G; Kilcoyne C; Coveney C; Devine H; Walsh JM; Higgins M; Hatunic M
Diabetes Ther; 2022 Mar; 13(3):481-487. PubMed ID: 35190969
[TBL] [Abstract][Full Text] [Related]
4. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.
Kutney K; Donnola SB; Flask CA; Gubitosi-Klug R; O'Riordan M; McBennett K; Sferra TJ; Kaminski B
World J Hepatol; 2019 Dec; 11(12):761-772. PubMed ID: 31966908
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy rates and outcomes in women with cystic fibrosis in the UK: comparisons with the general population before and after the introduction of disease-modifying treatment, 2003-17.
Esan OB; Schlüter DK; Phillips R; Cosgriff R; Paranjothy S; Williams D; Norman R; Carr SB; Duckers J; Taylor-Robinson D
BJOG; 2022 Apr; 129(5):743-751. PubMed ID: 34597459
[TBL] [Abstract][Full Text] [Related]
6. Effect of CFTR modulator therapy on cystic fibrosis-related diabetes.
Gaines H; Jones KR; Lim J; Medhi NF; Chen S; Scofield RH
J Diabetes Complications; 2021 Jun; 35(6):107845. PubMed ID: 33558149
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes in women with gestational diabetes mellitus by models of care: a retrospective cohort study.
Harrison J; Melov S; Kirby AC; Athayde N; Boghossian A; Cheung W; Inglis E; Maravar K; Padmanabhan S; Luig M; Hook M; Pasupathy D
BMJ Open; 2022 Sep; 12(9):e065063. PubMed ID: 36167384
[TBL] [Abstract][Full Text] [Related]
8. Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis.
Ødegaard I; Stray-Pedersen B; Hallberg K; Haanaes OC; Storrøsten OT; Johannesson M
Acta Obstet Gynecol Scand; 2002 Aug; 81(8):698-705. PubMed ID: 12174152
[TBL] [Abstract][Full Text] [Related]
9. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
Moheet A; Moran A
J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
[TBL] [Abstract][Full Text] [Related]
10. Cystic Fibrosis-Related Diabetes.
Kayani K; Mohammed R; Mohiaddin H
Front Endocrinol (Lausanne); 2018; 9():20. PubMed ID: 29515516
[TBL] [Abstract][Full Text] [Related]
11. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
12. Effect of maternal cystic fibrosis genotype on diabetes in pregnancy.
Giacobbe LE; Nguyen RH; Aguilera MN; Mikhaelian M; Jacobs K; Ramin KD; Yamamura Y
Obstet Gynecol; 2012 Dec; 120(6):1394-9. PubMed ID: 23168765
[TBL] [Abstract][Full Text] [Related]
13. Fertility and Pregnancy in Cystic Fibrosis.
Shteinberg M; Taylor-Cousar JL; Durieu I; Cohen-Cymberknoh M
Chest; 2021 Dec; 160(6):2051-2060. PubMed ID: 34284004
[TBL] [Abstract][Full Text] [Related]
14. Prenatal Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Promising Way to Change the Impact of Cystic Fibrosis.
Gómez-Montes E; Salcedo Lobato E; Galindo Izquierdo A; García Alcázar D; Villalain González C; Moral-Pumarega MT; Bustos Lozano G; Luna-Paredes C
Fetal Diagn Ther; 2023; 50(2):136-142. PubMed ID: 36996799
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy in cystic fibrosis. Fetal and maternal outcome.
Gilljam M; Antoniou M; Shin J; Dupuis A; Corey M; Tullis DE
Chest; 2000 Jul; 118(1):85-91. PubMed ID: 10893364
[TBL] [Abstract][Full Text] [Related]
16. Effects of modulator therapies on endocrine complications in adults with cystic fibrosis: a narrative review.
Kumar S; Soldatos G; Teede HJ; Pallin M
Med J Aust; 2023 Nov; 219(10):496-502. PubMed ID: 37839059
[TBL] [Abstract][Full Text] [Related]
17. Current pregnancy outcomes in women with cystic fibrosis.
Burden C; Ion R; Chung Y; Henry A; Downey DG; Trinder J
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):142-5. PubMed ID: 22784584
[TBL] [Abstract][Full Text] [Related]
18. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome in women with cystic fibrosis-related diabetes.
Reynaud Q; Poupon-Bourdy S; Rabilloud M; Al Mufti L; Rousset Jablonski C; Lemonnier L; Nove-Josserand R; Touzet S; Durieu I;
Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1223-1227. PubMed ID: 28646623
[TBL] [Abstract][Full Text] [Related]
20. The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes.
Hasan S; Khan MS; Lansang MC
J Clin Transl Endocrinol; 2022 Sep; 29():100301. PubMed ID: 35746945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
